Novo Nordisk's U.S.-listed and domestic shares rose Wednesday after analysts from UBS upgraded the Danish drugmaker's stock ...

FOIA requests to the federal government often are signals. They can be an important early warning of bad publicity, litigation to come, or uncertainties to be hedged and gamed out. When the flow of ...

In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...

Putting tariffs on Denmark unless it cedes the island of Greenland could hurt access to a few key products, including popular ...

Whether this year’s big job commitments sink or swim will be known in time. But for now, let’s explore the dreams.

Novo Nordisk, the maker of perhaps the most sought-after prescription drugs in the world, says Ozempic and Wegovy are now being shipped regularly to wholesalers. After a year where products were ...

It is best known for manufacturing diabetes medications, including Ozempic and Wegovy. Ozempic is used to treat obesity and regulate blood-sugar levels. It accounted for roughly $13.9 billion ...

It’s not at all clear what a tariff would mean for Novo, which manufactures its medicines in facilities all over the world, ...

Danish pharma company Novo Nordisk, makers of weight-loss drugs Ozempic and Wegovy, plans to expand production based on a takeover of US health products manufacturer Catalent, in a deal worth $11. ...

Shares in Novo Nordisk have fallen by more than a quarter after the Ozempic maker revealed a set of underwhelming ... a more effective successor to its Wegovy weight-loss jab.